{"id":"https://openalex.org/W2494481908","doi":"https://doi.org/10.17925/eoh.2014.10.1.35","title":"Triple Negative Breast Cancer Pathologic Diagnosis and Current Chemotherapy Treatment Options","display_name":"Triple Negative Breast Cancer Pathologic Diagnosis and Current Chemotherapy Treatment Options","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2494481908","doi":"https://doi.org/10.17925/eoh.2014.10.1.35","mag":"2494481908"},"language":"en","primary_location":{"id":"doi:10.17925/eoh.2014.10.1.35","doi":"https://doi.org/10.17925/eoh.2014.10.1.35","is_oa":false,"landing_page_url":"https://doi.org/10.17925/eoh.2014.10.1.35","pdf_url":null,"source":{"id":"https://openalex.org/S2764596299","display_name":"European Oncology & Haematology","issn_l":"2045-5275","issn":["2045-5275","2045-5283","2045-5291"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4404675657","host_organization_name":"Touch Medical Media","host_organization_lineage":["https://openalex.org/P4404675657"],"host_organization_lineage_names":["Touch Medical Media"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Oncology & Haematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043177871","display_name":"Bernardo Leon Rapoport","orcid":"https://orcid.org/0000-0001-7610-3653","observed_orcids":["https://orcid.org/0000-0001-7610-3653"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bernardo L Rapoport","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021761967","display_name":"Simon Nayler","orcid":"https://orcid.org/0000-0002-5041-7811","observed_orcids":["https://orcid.org/0000-0002-5041-7811"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simon Nayler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040735233","display_name":"Georgia Savva Demetriou","orcid":"https://orcid.org/0000-0002-9029-0069","observed_orcids":["https://orcid.org/0000-0002-9029-0069"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Georgia S Demetriou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102974331","display_name":"Shun Devan Moodley","orcid":"https://orcid.org/0000-0003-2994-1915","observed_orcids":["https://orcid.org/0000-0003-2994-1915"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shun D Moodley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5001298706","display_name":"Carol\u2010Ann Benn","orcid":"https://orcid.org/0000-0002-4777-4316","observed_orcids":["https://orcid.org/0000-0002-4777-4316"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carol A Benn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2965,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.52610536,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"10","issue":"01","first_page":"35","last_page":"35"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":1.0},{"id":"https://openalex.org/keywords/pathological-diagnosis","display_name":"pathological diagnosis","score":0.6690000295639038},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8920000195503235},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.9940000176429749},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/platinum-agents","display_name":"platinum agents","score":0.6729999780654907},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.800000011920929},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.5770000219345093},{"id":"https://openalex.org/keywords/her2-status","display_name":"HER2 status","score":0.8289999961853027},{"id":"https://openalex.org/keywords/chemotherapy-regimens","display_name":"chemotherapy regimens","score":0.6340000033378601},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.884655773639679},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.8018696308135986},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.7495822906494141},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7162581086158752},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6648478507995605},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6400694251060486},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5698465704917908},{"id":"https://openalex.org/C98717036","wikidata":"https://www.wikidata.org/wiki/Q14872994","display_name":"Progesterone receptor","level":5,"score":0.5297737121582031},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4813719391822815},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.4667527973651886},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.45066016912460327},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4192132353782654},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.2586023509502411}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.17925/eoh.2014.10.1.35","doi":"https://doi.org/10.17925/eoh.2014.10.1.35","is_oa":false,"landing_page_url":"https://doi.org/10.17925/eoh.2014.10.1.35","pdf_url":null,"source":{"id":"https://openalex.org/S2764596299","display_name":"European Oncology & Haematology","issn_l":"2045-5275","issn":["2045-5275","2045-5283","2045-5291"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4404675657","host_organization_name":"Touch Medical Media","host_organization_lineage":["https://openalex.org/P4404675657"],"host_organization_lineage_names":["Touch Medical Media"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Oncology & Haematology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7099002766","https://openalex.org/W1771695328","https://openalex.org/W6927614577","https://openalex.org/W1746134487","https://openalex.org/W2162632391","https://openalex.org/W1993779806","https://openalex.org/W2135967835","https://openalex.org/W3199183216","https://openalex.org/W2986569805","https://openalex.org/W4301877415"],"abstract_inverted_index":{"Triple":[0],"negative":[1],"breast":[2,10,179,211],"cancer":[3,180],"(TNBC)":[4],"comprises":[5],"12\u201320":[6],"%":[7],"of":[8,17,30,32,47,52,75,77,89,99,124,204,209,233,238,244,247,265,285,288],"all":[9],"cancers":[11,24],"and":[12,21,39,66,84,126,142,186,235,267,279],"are":[13,25,137,226],"a":[14,103,201,245,251],"heterogeneous":[15],"group":[16],"tumours,":[18],"both":[19],"clinically":[20],"pathologically.":[22],"These":[23],"characterised":[26],"by":[27],"the":[28,33,45,53,73,81,97,143,207,219,229,236,242,262,268,276],"lack":[29,46,88],"expression":[31],"hormone":[34,176],"receptors":[35],"oestrogen":[36],"receptor":[37,41,177],"(OR)":[38],"progesterone":[40],"(PR),":[42],"combined":[43],"with":[44,175,183,190,197],"either":[48],"overexpression":[49],"or":[50,146],"amplification":[51],"human":[54],"epidermal":[55],"growth":[56],"factor":[57],"receptor-2":[58],"(":[59],"HER2":[60],")":[61],"gene.":[62],"Conventional":[63],"cytotoxic":[64],"chemotherapy":[65,135],"DNA":[67],"damaging":[68],"agents":[69,112,145,225],"continue":[70],"to":[71,272],"be":[72],"mainstay":[74],"treatment":[76,98,217,269],"this":[78],"disease":[79],"in":[80,92,105,108,117,140,155,206,275],"neoadjuvant,":[82,277],"adjuvant":[83,278],"metastatic":[85,210,221,280],"setting.":[86,222],"The":[87],"predictive":[90],"markers":[91],"identifying":[93],"potential":[94],"targets":[95],"for":[96,149,193,200,218],"TNBC":[100,118,150,165,198,234,266],"has":[101,166],"left":[102],"gap":[104],"directed":[106],"therapy":[107],"these":[109,194,273],"patients.":[110,195],"Platinum":[111],"have":[113,151,161],"seen":[114],"renewed":[115],"interest":[116],"based":[119],"on":[120],"an":[121,283],"increasing":[122],"body":[123],"preclinical":[125],"clinical":[127],"data":[128],"suggesting":[129],"encouraging":[130],"activity.":[131],"However,":[132],"comparisons":[133],"between":[134],"regimens":[136],"mostly":[138],"retrospective":[139],"nature":[141,232],"best":[144],"drug":[147],"combinations":[148],"not":[152],"been":[153],"established":[154],"prospective":[156],"randomised":[157],"trials.":[158],"Numerous":[159],"studies":[160],"now":[162],"shown":[163],"that":[164],"significantly":[167],"higher":[168],"pathological":[169,263],"complete":[170],"response":[171],"(pCR)":[172],"rates":[173],"compared":[174],"positive":[178],"when":[181],"treated":[182],"neoadjuvant":[184],"chemotherapy,":[185],"pCR":[187],"correlates":[188],"well":[189],"better":[191],"outcomes":[192],"Patients":[196],"account":[199],"larger":[202],"number":[203],"deaths":[205],"setting":[208],"cancer.":[212],"There":[213],"is":[214,254],"no":[215],"preferred":[216],"first-line":[220],"Although":[223],"individual":[224],"recommended,":[227],"given":[228],"often":[230,255],"aggressive":[231],"presence":[237],"extensive":[239],"visceral":[240],"disease,":[241],"use":[243],"combination":[246],"drugs,":[248],"rather":[249],"than":[250],"single":[252],"agent,":[253],"advocated.":[256],"This":[257],"review":[258],"article":[259],"will":[260],"outline":[261],"diagnosis":[264],"options":[270],"available":[271],"patients":[274],"setting,":[281],"including":[282],"assessment":[284],"future":[286],"directions":[287],"treatment.":[289]},"counts_by_year":[{"year":2022,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":6},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-08-23T00:00:00"}